产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 |
CAS No. |
1421448-26-1 |
|---|---|
中文名称 |
N-(2,3-二氢苯并[b][1,4]二氧杂环己烷基-6-基)-1,4-二氢茚并[1,2-c]吡唑-3-胺 |
英文名称 |
N-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
别名 |
N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine;GN 44028;Indeno[1,2-c]pyrazol-3-amine, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,4-dihydro-;2-c]pyrazol-3-amine;4-benzodioxin-6-yl)-1;4-dihydroindeno[1;GN 44028,colorectal cancer,HIFs,Hypoxia,HeLa,ME23,GSCs,HIF/HIF Prolyl-Hydroxylase,inhibit,GN-44028,HCT116,cancer,heterodimerization,HIF-PH,GN44028,Hypoxia-inducible factors,PN12,Inhibitor;N-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
标准英文名 |
N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
分子式 |
C18H15N3O2 |
分子量 |
305.34 |
精确分子量 |
305.12 |
SMILES |
C12=C(CC3=C2C=CC=C3)C(NC4=CC=C(OCCO5)C5=C4)=NN1 |
标准SMILES |
C1C2=C(NN=C2NC2C=C3OCCOC3=CC=2)C2C=CC=CC=21 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
CGZKSZVSWAAUHE-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Keep in dark place, Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|